Search research articles
Contact Us
Filters
Showing results (201-210 of 333) with videos related to
Page
of 34
Sort By:
Progress in Neurobiology
|
December 7, 2010
Biomarkers for Alzheimer's disease therapeutic trials
Harald Hampel, Gordon Wilcock, Sandrine Andrieu, et al.
Plos One
|
October 3, 2012
Plasma based markers of [11C] PiB-PET brain amyloid burden
Steven John Kiddle, Madhav Thambisetty, Andrew Simmons, et al.
Frontiers in Aging Neuroscience
|
August 9, 2021
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies
Liu Shi, Noel J Buckley, Isabelle Bos, et al.
JAMA Neurology
|
November 19, 2019
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial
Robert Howard, Olga Zubko, Rosie Bradley, et al.
Alzheimer'S Research & Therapy
|
April 27, 2017
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology
Sarah Westwood, Benjamine Liu, Alison L Baird, et al.
Journal of Alzheimer'S Disease : JAD
|
October 15, 2013
Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study
Steven J Kiddle, Martina Sattlecker, Petroula Proitsi, et al.
Alzheimer'S Research & Therapy
|
April 8, 2020
Methotrexate and relative risk of dementia amongst patients with rheumatoid arthritis: a multi-national multi-database case-control study
Danielle Newby, Daniel Prieto-Alhambra, Talita Duarte-Salles, et al.
Journal of Alzheimer'S Disease : JAD
|
December 3, 2016
Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease
Min Kim, Alejo Nevado-Holgado, Luke Whiley, et al.
Neuroscience Letters
|
August 4, 2004
Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study
Yonghong Li, Kristina Tacey, Lisa Doil, et al.
Brain Communications
|
January 25, 2023
Identification of a possible proteomic biomarker in Parkinson's disease: discovery and replication in blood, brain and cerebrospinal fluid
Laura Winchester, Imelda Barber, Michael Lawton, et al.
Page
of 34
Search research articles
Search
Showing results (201-210 of 333) with videos related to
Sort By:
Page
of 34
Progress in Neurobiology
|
December 7, 2010
Biomarkers for Alzheimer's disease therapeutic trials
Harald Hampel, Gordon Wilcock, Sandrine Andrieu, et al.
Plos One
|
October 3, 2012
Plasma based markers of [11C] PiB-PET brain amyloid burden
Steven John Kiddle, Madhav Thambisetty, Andrew Simmons, et al.
Frontiers in Aging Neuroscience
|
August 9, 2021
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies
Liu Shi, Noel J Buckley, Isabelle Bos, et al.
JAMA Neurology
|
November 19, 2019
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial
Robert Howard, Olga Zubko, Rosie Bradley, et al.
Alzheimer'S Research & Therapy
|
April 27, 2017
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology
Sarah Westwood, Benjamine Liu, Alison L Baird, et al.
Journal of Alzheimer'S Disease : JAD
|
October 15, 2013
Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study
Steven J Kiddle, Martina Sattlecker, Petroula Proitsi, et al.
Alzheimer'S Research & Therapy
|
April 8, 2020
Methotrexate and relative risk of dementia amongst patients with rheumatoid arthritis: a multi-national multi-database case-control study
Danielle Newby, Daniel Prieto-Alhambra, Talita Duarte-Salles, et al.
Journal of Alzheimer'S Disease : JAD
|
December 3, 2016
Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease
Min Kim, Alejo Nevado-Holgado, Luke Whiley, et al.
Neuroscience Letters
|
August 4, 2004
Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study
Yonghong Li, Kristina Tacey, Lisa Doil, et al.
Brain Communications
|
January 25, 2023
Identification of a possible proteomic biomarker in Parkinson's disease: discovery and replication in blood, brain and cerebrospinal fluid
Laura Winchester, Imelda Barber, Michael Lawton, et al.
Page
of 34